This website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
This Website Uses Cookies By closing this message or continuing to use our site, you agree to our cookie policy. Learn MoreThis website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
Rather than using separated spaces for different aspects of pharmaceutical manufacturing as is typical, this plant was built with a single main “ballroom” to allow for adaptable modules that can be switched and scaled up as new treatments advance from R&D to commercial production, the team says.
In addition to being ready for rapid turnover for new treatments, the design allows the manufacturer to easily replace equipment as new technology becomes available, says Kevin Ng, vice president of science and technology at XL Construction. “Each of the bays was designed to receive any of the different modules that [owner Genentech] may want to swap out in the future,” he says. “So, they have consistent utilities, consistent power, consistent sizing and a flexible grid of anchors in the floor that could receive different size modules as they change in the future.”